drugset / Trial / NCT05360134

Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation

NCT05360134

RandomizedParallel-groupSingle-blindTreatment

Summary

This project is a pilot randomized controlled trial aimed at investigating the potential of Carica Papaya Leaf Extract, available in a marketed pill formulation, in increasing platelet counts in live donor liver transplant recipients. Carica Papaya leaf extract has shown positive results in increasing platelet counts in various medical conditions such as Dengue, Immune thrombocytopenic purpura and chemotherapy induced thrombocytopenia. Thrombocytopenia i.e. low platelet counts are a common occurrence in patients with chronic liver disease undergoing live donor liver transplant. It has been observed in previous studies that live donor liver transplant recipients who have persistent thrombocytopenia have significantly worse outcomes as compared to patients who have higher platelet counts. Positive results in this study lead to further studies in assessing the impact of platelet augmentation in live donor liver transplant recipients.

Timeline

Start
2021-01-01
Primary completion
2022-10-01
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Carica Papaya Leaf Extract Unknown 1100 mg

Indications